Original Query: ALL
Previous Study | Return to List | Next Study

A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01561833
Recruitment Status : Completed
First Posted : March 23, 2012
Last Update Posted : February 19, 2015
Information provided by (Responsible Party):
Yale University

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : May 2013
  Study Completion Date : June 2013

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 15, 2016 July 25, 2016
2 October 13, 2017